In this section, we summarize all the types of cells that secrete EVs that can potentially modify the drug sensitivity of PDAC to chemotherapeutic agents, including CAFs, TAMs, PDAC, cancer stem cells, and GIPC-depleted pancreatic cells or pancreatic cells sensitized to GEM. This evidence concerns the gene GIPC1 and cancer.